Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZOE.DE
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.80 3.33 3.36
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -7.56 5.03 5.44
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.86 11.04 10.84
Cash 198.83 13.22 4.42
Capex 28.85 -0.31 -0.43
Free Cash Flow -34.50 0.99 1.52
Revenue -0.42 4.78 4.80
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 5.27 0.71 0.67
Operating Margin 9.23 0.37 0.33
ROA 13.60 0.04 0.04
ROE 12.72 0.12 0.11
ROIC 7.04 0.05 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZOE.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZOE.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZOE.DE is permitted for members.